TR201722102A2 - Levodropropizin İçeren Farmasötik Bir Ürün - Google Patents

Levodropropizin İçeren Farmasötik Bir Ürün Download PDF

Info

Publication number
TR201722102A2
TR201722102A2 TR2017/22102A TR201722102A TR201722102A2 TR 201722102 A2 TR201722102 A2 TR 201722102A2 TR 2017/22102 A TR2017/22102 A TR 2017/22102A TR 201722102 A TR201722102 A TR 201722102A TR 201722102 A2 TR201722102 A2 TR 201722102A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical product
product containing
levodropropizine
containing levodropropizine
cough
Prior art date
Application number
TR2017/22102A
Other languages
English (en)
Inventor
Kandemi̇rer Ürün
Çi̇fter Ümi̇t
Mutlu Şentürk Ayli̇n
Original Assignee
Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/22102A priority Critical patent/TR201722102A2/tr
Priority to PCT/TR2018/050654 priority patent/WO2019132823A1/en
Publication of TR201722102A2 publication Critical patent/TR201722102A2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Abstract

Buluş; öksürüğün semptomatik tedavisinde kullanılmak üzere; levodropropizin etken maddesi içeren çiğneme tableti formunda oral bir farmasötik ürün ile ilgilidir.
TR2017/22102A 2017-12-27 2017-12-27 Levodropropizin İçeren Farmasötik Bir Ürün TR201722102A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/22102A TR201722102A2 (tr) 2017-12-27 2017-12-27 Levodropropizin İçeren Farmasötik Bir Ürün
PCT/TR2018/050654 WO2019132823A1 (en) 2017-12-27 2018-11-05 A pharmaceutical product comprising levodropropizine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/22102A TR201722102A2 (tr) 2017-12-27 2017-12-27 Levodropropizin İçeren Farmasötik Bir Ürün

Publications (1)

Publication Number Publication Date
TR201722102A2 true TR201722102A2 (tr) 2019-07-22

Family

ID=67067912

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/22102A TR201722102A2 (tr) 2017-12-27 2017-12-27 Levodropropizin İçeren Farmasötik Bir Ürün

Country Status (2)

Country Link
TR (1) TR201722102A2 (tr)
WO (1) WO2019132823A1 (tr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100544722C (zh) * 2006-10-12 2009-09-30 朱志宏 一种口腔内使用的左羟丙哌嗪药物组合物
CN101176730A (zh) * 2006-11-07 2008-05-14 朱志宏 一种药物组合物及其制备工艺

Also Published As

Publication number Publication date
WO2019132823A1 (en) 2019-07-04

Similar Documents

Publication Publication Date Title
CY1122730T1 (el) 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων
MY196173A (en) Cot Modulators And Methods Of Use Thereof
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
BR112015023417A2 (pt) compostos heterocíclicos e seus usos
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
CL2018001199A1 (es) Composiciones terapéuticas para el tratamiento del virus de inmunodeficiencia humana
DOP2017000306A (es) Formulaciones farmacéuticas que contienen tenofovir y emtricitabina
EA201792591A1 (ru) Фармацевтические препараты
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
PH12015500823A1 (en) Modified release formulations for oprozomib
CL2016001094A1 (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
MX2016002560A (es) Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir.
UY35690A (es) Composiciones farmacéuticas de ranolazina y dronedarona
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
TR201722102A2 (tr) Levodropropizin İçeren Farmasötik Bir Ürün
MX370184B (es) Composición farmacéutica que comprende fingolimod.
CL2016000182A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
TR201821115A2 (tr) Montelukast ve levoseti̇ri̇zi̇n i̇çeren farmasöti̇k bi̇leşi̇m
TR201815617A2 (tr) Deksketoprofen içeren bir formülasyon.
WO2019004984A3 (en) PHARMACEUTICAL FORMULATION COMPRISING CHOLECALCIFEROL
UA113442C2 (xx) Ентеросорбент
TR201818990A2 (tr) Sefdi̇ni̇r i̇çeren tablet formülasyonu
UA120295U (uk) Лікарській засіб антитромбоцитарної дії